Labcorp Holdings [LH] vs Idexx Laboratories [IDXX] Detailed Stock Comparison

Labcorp Holdings Inc.

NYSE
Loading...

Idexx Laboratories, Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Labcorp Holdings Inc. wins in 9 metrics, Idexx Laboratories, Inc. wins in 11 metrics, with 0 ties. Idexx Laboratories, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Labcorp Holdings Inc. Idexx Laboratories, Inc. Better
P/E Ratio (TTM) 25.30 42.92 Labcorp Holdings Inc.
Price-to-Book Ratio 2.53 27.85 Labcorp Holdings Inc.
Debt-to-Equity Ratio 75.56 60.83 Idexx Laboratories, Inc.
PEG Ratio 1.55 2.41 Labcorp Holdings Inc.
EV/EBITDA 12.70 31.12 Labcorp Holdings Inc.
Profit Margin (TTM) 6.28% 24.62% Idexx Laboratories, Inc.
Operating Margin (TTM) 10.55% 29.76% Idexx Laboratories, Inc.
EBITDA Margin (TTM) 10.55% 29.76% Idexx Laboratories, Inc.
Return on Equity 10.51% 66.20% Idexx Laboratories, Inc.
Return on Assets (TTM) 5.12% 25.59% Idexx Laboratories, Inc.
Free Cash Flow (TTM) $1.21B $1.04B Labcorp Holdings Inc.
Dividend Yield 1.00% N/A N/A
1-Year Return 4.45% 9.77% Idexx Laboratories, Inc.
Price-to-Sales Ratio (TTM) 1.56 10.38 Labcorp Holdings Inc.
Enterprise Value $27.84B $46.85B Idexx Laboratories, Inc.
EV/Revenue Ratio 2.00 10.89 Labcorp Holdings Inc.
Gross Profit Margin (TTM) 28.25% 60.35% Idexx Laboratories, Inc.
Revenue per Share (TTM) $168 $54 Labcorp Holdings Inc.
Earnings per Share (Diluted) $10.47 $13.07 Idexx Laboratories, Inc.
Beta (Stock Volatility) 0.99 1.72 Labcorp Holdings Inc.
Short % of Float 3.90% 2.74% Idexx Laboratories, Inc.

Labcorp Holdings Inc. vs Idexx Laboratories, Inc. Stock Performance Analysis

Loading Price Chart...

LH
IDXX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Labcorp Holdings Inc.0.47%-0.27%1.87%-10.03%-3.08%2.42%
Idexx Laboratories, Inc.1.80%-1.21%-2.25%-13.54%-24.87%-17.84%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Labcorp Holdings Inc.4.45%39.51%13.65%134.84%211.71%405.07%
Idexx Laboratories, Inc.9.77%19.69%0.93%539.65%1,408.78%2,730.39%

Performance & Financial Health Analysis: Labcorp Holdings Inc. vs Idexx Laboratories, Inc.

MetricLHIDXX
Market Information
Market Cap i$21.83B$44.66B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i623,855480,502
90 Day Avg. Volume i582,012516,114
Last Close$258.92$560.73
52 Week Range$241.81 - $293.72$506.91 - $769.98
% from 52W High-11.85%-27.18%
All-Time High$293.72 (Oct 21, 2025)$769.98 (Nov 26, 2025)
% from All-Time High-11.85%-27.18%
Growth Metrics
Quarterly Revenue Growth0.06%0.14%
Quarterly Earnings Growth0.15%0.15%
Financial Health
Profit Margin (TTM) i0.06%0.25%
Operating Margin (TTM) i0.11%0.30%
Return on Equity (TTM) i0.11%0.66%
Debt to Equity (MRQ) i75.5660.83
Cash & Liquidity
Book Value per Share (MRQ)$104.86$20.14
Cash per Share (MRQ)$6.46$2.26
Operating Cash Flow (TTM) i$1.64B$1.18B
Levered Free Cash Flow (TTM) i$966.63M$790.74M
Dividends
Last 12-Month Dividend Yield i1.00%N/A
Last 12-Month Dividend i$2.88N/A

Valuation & Enterprise Metrics Analysis: Labcorp Holdings Inc. vs Idexx Laboratories, Inc.

MetricLH (Apr 24, 2026)IDXX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i25.3042.92
Forward P/E i13.7434.19
PEG Ratio i1.552.41
Price to Sales (TTM) i1.5610.38
Price to Book (MRQ) i2.5327.85
Market Capitalization
Market Capitalization i$21.83B$44.66B
Enterprise Value i$27.84B$46.85B
Enterprise Value Metrics
Enterprise to Revenue i2.0010.89
Enterprise to EBITDA i12.7031.12
Risk & Other Metrics
Beta i0.991.72
Book Value per Share (MRQ) i$104.86$20.14

Financial Statements Comparison: Labcorp Holdings Inc. vs Idexx Laboratories, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLH (2025)IDXX (2025)
Revenue/Sales i13.95B4.30B
Cost of Goods Sold i9.94B1.64B
COGS % of Revenue i71.2%38.2%
Gross Profit i4.01B2.66B
Gross Margin i28.8%61.8%
Research & Development iN/A251.21M
Operating Income (EBIT) i1.52B1.36B
Operating Margin i10.9%31.6%
EBITDA i2.13B1.51B
EBITDA Margin i15.3%35.0%
Pre-Tax Income i1.11B1.32B
Pre-Tax Income % of Revenue i7.9%30.8%
Income Tax i229.80M264.73M
Income Tax % of Revenue i1.6%6.2%
Net Income (Profit) i877.70M1.06B
Profit Margin i6.3%24.6%

Balance Sheet & Liquidity Metrics

MetricLH (2025)IDXX (2025)
Cash & Equivalents i532.30M180.07M
Total Current Assets i4.02B1.41B
Total Current Assets % of Revenue i28.8%32.9%
Total Current Liabilities i2.82B1.15B
Total Current Liabilities % of Revenue i20.2%26.7%
Long-Term Debt i5.83B475.99M
Long-Term Debt % of Revenue i41.8%11.1%
Total Shareholders Equity i8.64B1.61B
Retained Earnings i8.64B6.39B
Retained Earnings % of Revenue i61.9%148.5%
Property, Plant & Equipment i803.90M123.23M

Cash Flow Statement Comparison

MetricLH (2025)IDXX (2025)
Operating Cash Flow i1.99B1.17B
Operating Cash Flow % of Revenue i14.3%27.3%
Capital Expenditures iN/A-124.68M
Free Cash Flow i1.21B1.04B
FCF Margin i8.6%24.2%
Debt Repayment i-1.06B-428.39M
Common Stock Repurchase i-450.00M-1.22B

Short Interest & Institutional Ownership Analysis

MetricLHIDXX
Shares Short i3.19M1.91M
Short Ratio i5.833.85
Short % of Float i3.90%2.74%
Shares Outstanding i82.20M79.71M
Float Shares i82.00M78.75M
% Held by Insiders i0.36%0.71%
% Held by Institutions i100.64%96.04%
% Held by Public i-1.00%3.25%

Dividend Analysis & Yield Comparison: Labcorp Holdings Inc. vs Idexx Laboratories, Inc.

MetricLHIDXX
Last 12-Month Dividend i$2.88N/A
Last 12-Month Dividend Yield i1.00%N/A
3-Year Avg Annual Dividend i$3.09N/A
3-Year Avg Dividend Yield i0.31%N/A
3-Year Total Dividends i$9.26N/A
Ex-Dividend DateFeb 27, 2026N/A